(19)
(11) EP 3 898 972 A1

(12)

(43) Date of publication:
27.10.2021 Bulletin 2021/43

(21) Application number: 19818190.1

(22) Date of filing: 18.12.2019
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
C12N 15/10(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/465; C12N 15/102; C12N 15/90; A61K 48/00; C12N 15/1135; C12N 2310/20
(86) International application number:
PCT/EP2019/085957
(87) International publication number:
WO 2020/127487 (25.06.2020 Gazette 2020/26)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 21.12.2018 EP 18215341

(71) Applicant: Aarhus Universitet
8000 Aarhus C (DK)

(72) Inventors:
  • HOLM, Christian, Kanstrup
    8520 Lystrup (DK)
  • LUO, Yonglun
    8250 Egå (DK)
  • STOUGAARD, Magnus
    8260 Viby J (DK)
  • MØLLER, Charlotte, Thornild
    8520 Lystrup (DK)
  • NYEGAARD, Mette
    9260 Gistrup (DK)

(74) Representative: Plougmann Vingtoft a/s 
Strandvejen 70
2900 Hellerup
2900 Hellerup (DK)

   


(54) CRISPR GENE THERAPY OF FUSION GENE RELATED CANCERS